DIA
Drug Information Association Logo

About DIA’s Canadian Annual Meeting

Untitled Document

There is recognition of the need to provide the patient and the health care professionals with increased accessibility to drug information and comprehensive drug labels. This meeting will explore how patients, health care professionals, industry and the regulator continue to evolve and liaise. Through this continuous evolution, the need to embrace changes to drug development, regulatory requirements, encourage global collaborations and transparency while placing patient safety and greater access to efficacious drugs at the forefront.

This meeting will include three major themes:

  • New Frontiers
  • Communications
  • New Realities

BENEFITS:

  • Leave with solutions for development strategy
  • Network with colleagues and stakeholders to discuss new ideas
  • Look at a particular operations topic from different angles
  • Interact with speakers representing patients, industry and regulatory agencies
  • Enhance awareness of scientific areas
  • Learn the latest regulatory initiatives

WHO SHOULD ATTEND:

  • Regulatory Affairs
  • Policy/Pharmacoeconomics
  • Clinical Development
  • Clinical Safety/Pharmacovigilance
  • Patient Safety
  • Medical Communications
  • Quality Operations

Register Online

© 2014